international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress



Overview | Agenda | Promotional Opportunities | Continuing Education | Grantors & Exhibitors | Travel/Hotel
Registration | Admin | Speaking Proposals | Webcast Log In | Past Conferences | Contact Us | Home





NINTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS

May 11 - 13, 2015

ATTEND ONSITE
WEBCAST ATTENDANCE
Crowne Plaza Brussels -
Le Palace
Brussels, Belgium
In your own office or home live via the Internet with 24/7 access for 6 months


KEYNOTE SPEAKERS

Robert Barrington, PhD
Executive Director, Transparency International-UK, London, UK

Richard Bergström
Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Former Director General, LIF Sweden, Brussels, Belgium

Marc de Garidel
Chairman and Chief Executive Officer, Ipsen, Vice President, European Federation of the, Pharmaceutical Industries and Associations (EFPIA), Knight, National Order of the Legion of Honor (France), Paris, France

Brendan Shaw, PhD
Assistant Director General, International Federation of Pharmaceutical, Manufacturers and Associations (IFPMA), Former Chief Executive, Medicines Australia, Geneva, Switzerland

FEATURING AN EFPIA STAKEHOLDER WORKSHOP (Registration Complimentary)
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is offering an independent EFPIA STAKEHOLDER WORKSHOP from 10:30 am to 3:00 pm on Monday, May 11, 2015.

Click here for complimentary registration.
COVERING
  • Data Privacy - Implications of the EU Regulation on Data Privacy
  • Working with Patient Organisations
  • Disclosure Code - Implementation Across Europe
  • Stakeholder Perspectives on Disclosure Implementation
  • Communicating Disclosure - Developing the Right Culture
FEATURING

Richard Bergström
Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Former Director General, LIF Sweden, Brussels, Belgium

Brendan Barnes
Director IP and Global Health, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Nicola Bedlington
Secretary General, European Patients' Forum (EPF), Former Director, European Disability Forum, Brussels, Belgium

Julie Bonhomme
Legal Affairs & Compliance Deputy Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Former Legal and Compliance Manager, Legal and Compliance Department, LEEM, Brussels, Belgium

Mieke Goossens
Legal Counsel, bij pharma.be, Brussels, Belgium

Jens Steen Ravn Jensen, MSc
Senior Manager, Novo Nordisk A/S, Denmark

Andrew Powrie-Smith
Director of Communications, European Federation of Pharmaceutical Industries and Associations (EFPIA), Former Director, The Association of the British Pharmaceutical Industry (ABPI), Brussels, Belgium

FEATURING PLENARY SESSIONS
  • Keynote Address: Innovation, Ethics and Compliance
  • Keynote Address: The C-Suite Perspective
  • European Commission Keynote Address
  • Transparency International Keynote Address
  • Global Chief Compliance Officer Roundtable
  • Understanding the New Life Sciences Marketplace
  • The New Marketplace: The Purchasers Perspective
  • Roundtable on Compliance Issues Raised by the Changing Marketplace
  • IFPMA International Codes Update
  • Global Transparency Roundtable
  • Anticorruption 2.0: Thinking Strategically/Managing Risks
  • Crafting the Compliance Program of the Future
  • The Evolution of the Role and Responsibility of Compliance Professionals
INTERNATIONAL PHARMA
CONGRESS IS

AND MINI SUMMITS
  • Mini Summit I: Basic Compliance Concepts and Skills I
  • Mini Summit II: How to Engage Medical Societies with Conference Organizers
  • Mini Summit III: Competition/Antitrust Law Update
  • Mini Summit IV: Global Transparency, Disclosure and Aggregate Spend Update
  • Mini Summit V: Annual Central and Eastern European (CEE) Compliance Update
  • Mini Summit VI: How Transparency Initiatives Impact Life Sciences Commercial Model Evolution; Changing Relationships with Healthcare Providers
  • Mini Summit VII: Basic Compliance Concepts and Skills II
  • Mini Summit VIII: Global Compliance Auditing and Monitoring Best Practices
  • Mini Summit VIX: What's Next in Global Compliance?
  • Mini Summit X: Clinical Trials Compliance
  • Mini Summit XI: Data Analytics Supporting Compliance Monitoring, Risk Prevention and Mitigation
  • Mini Summit XII: Advanced Strategies in Compliance Training
  • Mini Summit XIII: Annual Middle East/Africa European (MEA) Compliance Update
  • Mini Summit XIV: Medical Device Compliance Issues Update
  • Mini Summit XV: Advanced Issues in Anti-corruption Compliance
  • Mini Summit XVI: Best Practices in Third Party Supplier Management

A CHIEF COMPLIANCE OFFICERS ROUNDTABLE

Martin Fürle
Vice President, General Counsel & Chief Compliance Officer, DAIICHI SANKYO EUROPE GmbH, Munich, Germany

Thomas K. Hauser, LLM
Chief Compliance Officer, Siemens Healthcare, Board Member, ETHICS, Nürnberg, Germany

Mwana Lugogo
Corporate Officer, Global Compliance Officer, Takeda Pharmaceuticals International GmbH, Zurich, Switzerland

Jeff Rosenbaum
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance Novartis Oncology, Boston, MA, USA

Kris Curry
Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP, Former Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson, Philadelphia, PA, USA (Moderator)

THE NEW MARKETPLACE: THE PURCHASER PERSPECTIVE

Günter Danner, MA, PhD
Associate Director, European Representation, German Social Insurance, Brussels, Belgium

Klaus Hilleke, PhD
Chief Executive Officer and Head, Global Life Science Division, Simon-Kucher & Partners, Bonn, Germany

Frank Wartenberg, PhD
President, Central Europe, IMS Health, Frankfurt/Main, Germany

Andrew White
Head of Medicine Management - NHS, Greater Manchester Commissioning Support Unit, Manchester, UK

Olivier Wong, MD
Specialist in Family Medicine; Former Voting Member, French Transparency Committee, Paris, France

ANTICORRUPTION 2.0 PANEL

Ted Acosta, Esq.
Principal, Fraud Investigation & Dispute Services, EY, Former Senior Counsel, Office of Inspector General, United States Department of Health and Human Services, New York, NY, USA and Paris, France

France Chain
Senior Legal Analyst, Anti-Corruption Division, Organisation for Economic Co-operation and Development (OECD), Paris, France

Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY

Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA

CENTRAL AND EASTERN EUROPE (CEE) COMPLIANCE UPDATE

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

Madina Plieva, PhD
Legal Director, Association of International, Pharmaceutical Manufacturers (AIPM), Former Head of Legal Department, Kutafin Moscow State Law Academy, Moscow, Russia

Dumitru Uta, MD, MBA, CCEP
Ethics and Compliance Director, South-East Europe, Eli Lilly and Company, Bucharest, Romania

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland (Moderator)

MIDDLE EAST/AFRICA (MEA) COMPLIANCE ROUNDTABLE


Flavia Bollinger
Head Integrity and Compliance MENA (Middle East, North Africa), Novartis Pharma Services AG, Dubai, UAE

Zeynep Didem Degirmencioglu
Head of Compliance, Intercontinental Region, Merck KGaA, Istanbul, Turkey

Dr. Yacoub Haddad
Government Affairs Director MEAP Region, Abbvie, Chair, Pharmaceutical Research and Manufacturers Association, Gulf (PhRMAG), Dubai, UAE

Laura Nassar
Head of Compliance, Middle East Sub-Regions I & II, Hoffmann-La Roche Ltd. (Dubai Branch), Dubai, UAE

Khaled Mansour
Area Managing Director, Middle East, West Asia and Africa, Janssen, Chair, MEA Regional Ethics Group (LERB), Cairo, Egypt (Moderator)

FEATURED FACULTY

David Andersen
Partner, Pharmaceutical and Life Sciences Risk Assurance, PwC LLP, London, UK

Annalisa Ponchia Baccara, CMP, CMM
Executive Officer, European Society for Organ Transplantation (ESOT), Padova, Italy

Brian K. Beeler, MBA, JD
Senior Vice President, Legal and Chief Compliance Officer, Horizon Pharma, Dublin, Ireland

Andy Bender
President and Founder, Polaris, New York, NY, USA

Katrina Cahill
Global Transparency Lead, Biogen Idec, Weston, MA

Fiona Carlin, LLB
Managing Partner, European & Competition Law Practice, Baker & McKenzie, Brussels, Belgium

Laurent Clerc
Co-founder and Regulatory Affairs Expert, BMI-SYSTEM, London, UK

Holger Diener, PhD
Managing Director, Association of Voluntary, Self-Regulation for the Pharmaceutical Industry, Berlin, Germany

Suzanne Durdevic, LLM
Senior Director, General Counsel, EMEA, Boston Scientific International; Chair, Legal Affairs Focus Group, EUCOMED; Member, Strategic Committee, ETHICS, Paris, France

Kip Ebel, MBA
Principal, Ernst & Young, New York, NY

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Eva Gardyan-Eisenlohr
Esquire (Germany)/DIAP (ENA, Paris), General Counsel and Compliance Officer, Bayer Pharma AG, Member, Strategic Committee, ETHICS, Berlin, Germany

George Fife
Executive Director, Fraud Investigation & Dispute Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Former, Compliance & Internal Audit Leader, EMEA, GE Healthcare, Paris, France

Jacques Fontas
Executive Counsel, Compliance Leader, GE, Healthcare Europe; Member, Strategic Committee, ETHICS, Paris, France

Dario Ghoddousi
Senior Vice President Global Transparency and MDM Solutions, IMS Health, Paris, France

Cécile Gousset
Associate Vice President Compliance Risk Assessment, Education and Monitoring, Global Compliance, Sanofi, Member, Strategic Committee, ETHICS, Paris, France

Ulf H. Grundmann, JD
Partner, Life Science Practice Group, King and Spalding, Frankfurt, Germany

Catherine Higgs, MA Cantab
Senior Legal Counsel, AstraZeneca, Alderley, UK

Erinn Hutchinson
Partner, Advisory Services, PricewaterhouseCoopers, Philadelphia, PA

Carl Judge
Director, Fraud Investigation & Dispute Services, EY, London, UK

Jimi Kehlet
Manager, Assurance intelligence, Group Internal Audit, Novo Nordisk A/S, Bagsvaerd, Denmark

Isaure Kergall-Gayet, DEA-Law
Compliance & Business Integrity Director, France, Global Compliance & Business Integrity Department, Sanofi, Former VP, Chief Ethics & Compliance Officer, Ipsen, Paris, France

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA

Aline Lautenberg
General Counsel - Director Legal & Compliance, Eucomed, EDMA and MedTech Europe, Brussels, Belgium

Angelique Lee-Rowley, Esq.
Vice President, Associate General Counsel and Compliance Officer Spectrum Pharmaceuticals, Inc., Former Director, Compliance, Siemens Healthcare, Irvine, CA, USA

Alice Lex, PhD
Health Care Compliance Officer, Janssen Research and Development in EMEA, Johnson & Johnson, Neuss, Germany

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, Washington, DC, USA

Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium

Stephen Nguyen-Duc
Office of Ethics & Compliance Regional Director . International Operations, Western Europe & Canada, Abbvie, Former Director, Ethics & Compliance Officer, Member of the Executive Committee, Eli Lilly, Member, Strategic Committee Member, ETHICS, Paris, France

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK

Pascale Paimbault
Compliance Officer, France -Benelux, Biogen, Treasurer and Strategic Committee Member, ETHICS, Former Chief Compliance Officer EMEA, Wright Medical Inc., Former Senior Director, Compliance and Ethics, Business Program, EMEA, Bristol-Myers Squibb, Paris, France

Gregoire Pavillon
Executive Director, European Association for the Study of the Liver (EASL), The Home of Hepatology, Geneva, Switzerland

Dr. Gudula Petersen
Chief Compliance Officer Europe & Australia, Grunenthal, Aachen, Germany

Katalin Pungor
Director, HCCO Pharma Emerging Markets, Johnson & Johnson, Budapest, Hungary

Nathalie Raynaud
Corporate Compliance Director, Global Compliance & Business Integrity Department, Sanofi, Paris, France

Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA

Christian-Claus Roth
Head Global Event Governance, Novartis, Pharma; Co-President, International Pharmaceutical Congress Advisory, Association (IPCAA), Berne, Switzerland

Guillaume Roussel
Director of Strategy, Veeva OpenKey, France

Fabien Roy, DESS European Law
Senior Associate, Hogan Lovells, Brussels, Belgium

Christine Sainvil
Compliance Officer, EthicalMedTech, Brussels, Belgium

Brian Sharkey, Esq.
Counsel, Porzio, Bromberg & Newman, Director of Compliance and Legal Affairs, Porzio Governmental Affairs, LLC, Morristown, NJ, USA

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority; Vice-Chair, IFPMA Code Compliance Network, London, UK

Nadine Sprangers
Senior Director Pricing, Reimbursement and Market Access, Daiichi Sankyo Europe GmbH, Munich, Germany

Nina Stoeckel, LLM
Head of Group Compliance Programs, Merck KGaA, Darmstadt, Germany

Michele Tagliaferri, Esq.
Counsel, Sidley Austin LLP, Brussels, Belgium

Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, Ernst & Young, London, UK

Marie Vandepaer
Senior Director Compliance Awareness and Solution-Corporate Compliance, UCB SA, Brussels Area, Belgium

Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium

Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain

2015 GLOBAL PHARMA COMPLIANCE CONGRESSES





REGISTER FOR COMPLIMENTARY EFPIA PRECONFERENCE STAKEHOLDER'S WORKSHOP
Click here to register.
SPONSORED BY:



CO-SPONSORED BY:



CONGRESS CO CHAIRS

Ann Beasley
Chief Compliance Officer, Biogen Idec International, GmbH, Former Global Compliance Officer, Novartis Pharma AG, Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Cambridge, MA, USA

Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Co-chair, EFPIA Compliance Workgroup, Munich, Germany

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Board Member, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
CONTINUING EDUCATION CREDITS
Accounting Professionals: Approved for up to 13 NASBE CPE credits.

Compliance Professionals: Approved for up to 13.0 Compliance Certification Board CCB Credits.

Attorneys:
  • Approved to offer a maximum of 12.50 Hours of Pennsylvania CLE Credits.
  • The Summit is currently pending approval to offer California MCLE Credit.

    Click here for more information.

  • GRANTORS:
    DIAMOND


    PLATINUM


    GOLD


    BRONZE


























    OTHER INTERNATIONAL PHARMA CONGRESSES

    2007 - Brussels


    2008 - Paris


    2009 - Rome


    2010 - Berlin


    2011 - Istanbul


    2011 - Singapore


    2012 - Budapest


    2012 - Shanghai


    2012 - São Paulo


    2013 - Madrid, Spain


    2013 - Kuala Lumpur


    2014 - Dubai


    2014 - Mexico City

    FOLLOW INTERNATIONAL PHARMA CONGRESS ON




    Tweet using #PharmaCongress
    PARTICIPATION OPTIONS
    TRADITIONAL ONSITE ATTENDANCE
    Simply register, travel to the conference city and attend in person.

    Pros: subject matter immersion; professional networking opportunities; faculty interaction


    LIVE AND ARCHIVED WEBCAST PARTICIPATION
    Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

    The archived conference includes speaker videos and coordinated PowerPoint presentations.

    Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





    WEBCAST INTERFACE SAMPLE

    Click here for a sample stream




    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.








    THE 2014 EIGHTH INTERNATIONAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE
    IN VARIOUS POST CONFERENCE FORMATS

    The 2014 Eighth International Pharma Congress conference content is now available in a variety of formats.

    You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

    YOU CAN PURCHASE JUST THE INTERNATIONAL PHARMA CONGRESS CONTENT AS FOLLOWS:

    Online Archive of 2014 Eighth International Pharma Congress Presentations today!
    Complete conference: $595
    Order Now

    Flash Drive of 2014 Eighth International Pharma Congress Presentations today!
    $595
    Order Now

    FINALLY YOU MAY PURCHASE INTERNATIONAL PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:
    Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).





    Overview | Agenda | Promotional Opportunities | Continuing Education | Grantors & Exhibitors | Travel/Hotel
    Registration | Admin | Speaking Proposals | Webcast Log In | Past Conferences | Contact Us | Home




    © Health Care Conference Administrators
    Contact Webmaster